Dorothy Normile

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Medicine · Health Sciences

8h-index235citations21works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dermatological diseases and infestations(15), Vector-borne infectious diseases(14), Bird parasitology and diseases(6), Insect and Pesticide Research(5), Helminth infection and control(3)

Publications21 total

Comparison of the initial and residual speed of Amblyomma americanum kill on dogs treated with a single dose of Bravecto® Chew (25 mg/kg fluralaner) or Simparica TRIO® (1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel)
Parasites & Vectors·2025Open Access
Comparison of the initial and residual speed of Ixodes scapularis kill on dogs treated with a single dose of Bravecto® Chew (25 mg/kg fluralaner) or Simparica TRIO® (1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel)
Parasites & Vectors·2023· 12 citedOpen Access
Treatment of dogs with Bravecto® (fluralaner) reduces mosquito survival and fecundity
Parasites & Vectors·2023· 9 citedOpen Access
Treatment of dogs with Bravecto® (fluralaner) reduces mosquito survival and fecundity
Research Square (Research Square)·2022· 1 citedOpen Access
An assessment of canine ectoparasiticide administration compliance in the USA
Parasites & Vectors·2022· 8 citedOpen Access
An assessment of canine ectoparasiticide administration compliance in the United States based on timing of ectoparasiticide purchases recorded in veterinary hospital transactions.
2021Open Access
Analysis of gaps in feline ectoparasiticide purchases from veterinary clinics in the United States
Parasites & Vectors·2021· 5 citedOpen Access
Flea and tick treatment satisfaction, preference, and adherence of US cat owners prescribed topical fluralaner (Bravecto® Topical Solution for Cats)
Open Veterinary Journal·2021· 5 citedOpen Access
Analysis of Gaps in Feline Ectoparasiticide Purchases from Veterinary Clinics in the United States.
2021Open Access
Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the U.S., U.K., or France who treated their cats with transdermal fluralaner
Open Veterinary Journal·2021· 6 citedOpen Access
Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA
Parasites & Vectors·2020· 8 citedOpen Access
Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA
Research Square (Research Square)·2020· 1 citedOpen Access
Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the United States of America.
Research Square (Research Square)·2020Open Access
Adherence to Veterinary Recommendations for Ectoparasiticides Purchased by Cat Owners in the United States.
Research Square (Research Square)·2020· 1 citedOpen Access
Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner
Open Veterinary Journal·2020· 9 citedOpen Access
Dog owner flea/tick medication purchases in the USA
Parasites & Vectors·2018· 23 citedOpen Access
In-home assessment of either topical fluralaner or topical selamectin for flea control in naturally infested cats in West Central Florida, USA
Parasites & Vectors·2018· 23 citedOpen Access
Ticks from cats in the United States: Patterns of infestation and infection with pathogens
Veterinary Parasitology·2018· 63 citedOpen Access
Assessment of dog owner adherence to veterinarians’ flea and tick prevention recommendations in the United States using a cross-sectional survey
Parasites & Vectors·2017· 57 citedOpen Access
Results from a U.S. Dog Owner Survey on the Treatment Satisfaction and Preference for Fluralaner against Flea and Tick Infestations
Journal of Veterinary Science & Technology·2017· 4 cited
page 1 of 2Next →

Frequent Co-authors

Robert P. Lavan(14), Rob Armstrong(10), Kathleen Heaney(6), W. E. Vaala(5), Imran Husain(4), Amita Singh(4), Brian H. Herrin(3), Kaan Tunceli(3), Michael W. Dryden(3), Robert Armstrong(3), Dongmu Zhang(2), Kathryn E. Reif(2), Naemi P. Bickmeier(2), Jeba R. J. Jesudoss Chelladurai(2), Qing Kang(2), Hannah Newbury(2), Christopher C. Evans(2), Sheryl Gamble(2), Frank Guerino(2), Michael T. Dzimianski(2)